Biocorp seeks to use Mallya device with Sanofi diabetes platform

Sanofi will make an initial payment of €4m to Biocorp as part of the exclusive negotiations. Credit: Sanofi de.



  • Biocorp seeks to use Mallya device with Sanofi’s diabetes platform